Stilonium

Stilonium

SCHEMBL10197132

CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 16/20 1.00
CYP1A2 P05177 2/20 1.00
MAPT P10636 1/20 1.00
KDM4E B2RXH2 1/20 1.00
MEN1 O00255 1/20 1.00
ALDH1A1 P00352 1/20 1.00
TP53 P04637 1/20 1.00
CYP2D6 P10635 1/20 1.00
HPGD P15428 1/20 1.00
ALOX15 P16050 1/20 1.00
KMT2A Q03164 1/20 1.00
HSD17B10 Q99714 1/20 1.00
CHRNB4 P30926 10/20 0.97
CHRNA3 P32297 10/20 0.97
CHRNA10 Q9GZZ6 5/20 0.97
CHRNA9 Q9UGM1 5/20 0.97
CHRNB2 P17787 4/20 0.97
CHRNA4 P43681 4/20 0.97
APOBEC3A P31941 1/20 0.97
CTDSP1 Q9GZU7 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stilonium SCHEMBL26104 0.98 CHRNA7 (1.00) CHRNA7CYP1A2MAPTKDM4EMEN1
Stilonium SCHEMBL26105 0.98 CHRNA7 (1.00) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL13385235 0.84 CHRNA7 (1.00) CHRNA7CYP1A2MAPTKDM4EMEN1
Hydrochloric Acid SCHEMBL11423649 0.83 CHRNA7 (0.96) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL5741015 0.81 RELA (0.72) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL1618632 0.81 RELA (0.72) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL80814 0.77 CHRNA7 (0.72) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL436231 0.77 RELA (1.00) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL5496245 0.77 RELA (1.00) CHRNA7CYP1A2MAPTKDM4EMEN1
SCHEMBL5739190 0.77 CHRNA7 (0.68) CHRNA7CYP1A2MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4218748-A2 BMP-MIMETICS Christian-Albrechts-Universität zu Kiel (DE) 2023-08-02 EP disclosed
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed
WO-2019042889-A1 BMP-MIMETICS TECHNISCHE UNIVERSITÄT DORTMUND (DE) 2019-03-07 WO disclosed
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 CHRNA7 4048/4885CYP1A2 3168/4885MAPT 2714/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 CHRNA7 4048/4885CYP1A2 3168/4885MAPT 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.